China International Capital Corp Ltd top stories

News dashboard

  • China’s Broad Homes plots Hong Kong listing

    Mainland firm Changsha Broad Homes Industrial Group has set the ball rolling for a Hong Kong IPO, submitting a draft prospectus to the bourse.

    • 18 Jan 2019
  • Yield-hungry investors buoy property bonds

    The party in Chinese high yield real estate bonds continued this week, with China Aoyuan Group, Zhenro Properties and Yuzhou Properties taking home $1.15bn between them on Tuesday.

    • 16 Jan 2019
  • BoCom Leasing adds $1.5bn to coffers with first 2019 bond

    China’s Bank of Communications Financial Leasing Co managed to raise the upper end of its $1.5bn target size at a tighter-than-expected level on Tuesday, a feat achieved despite a busy bond market in Asia.

    • 16 Jan 2019
  • Weimob prices IPO low to rake in $108m

    Tencent Holdings-backed Weimob raised HK$845m ($107.8m) after pricing its IPO at the bottom of the indicative range on Thursday, a bit behind the original schedule, according to a banker close to the deal.

    • 11 Jan 2019
  • Chengdu Expressway IPO flickers amid dull HK market

    Chengdu Expressway Co’s HK$880m ($112.3m) IPO has marked the start of a quiet week for the Hong Kong equity capital markets.

    • 07 Jan 2019
  • Weimob woos investors to $135m HK IPO

    Considerably cheap valuations have made Weimob, a Tencent Holdings-backed company that is on the road with its Hong Kong IPO, an attractive proposition for equity investors, according to a source close to the listing.

    • 02 Jan 2019
  • CIMC Vehicles revs up $500m Hong Kong IPO

    CIMC Vehicles Co is eyeing $500m from a Hong Kong IPO, with plans to launch the listing by the end of the first quarter, according to a source close to the deal.

    • 02 Jan 2019
  • Wuhan LGFV debuts with club-style bond

    Wuhan Financial Holdings Group Co made its dollar market debut on Monday, raising $142m from a three year club-style deal.

    • 18 Dec 2018
  • Fosun plans $800m Henlius Biotech spin-off

    Shanghai Henlius Biotech has joined a growing pipeline of biotechnology firms planning to float in Hong Kong. It wants to list in the first quarter of 2019, said a banker working on the transaction.

    • 17 Dec 2018
  • Junshi Bio seals $394m Hong Kong IPO

    Shanghai Junshi Biosciences has raised HK$3.08bn ($394.2m) after pricing its IPO at the bottom of the range, according to a banker on the deal.

    • 17 Dec 2018

China International Capital Corp Ltd In The Key League Tables

Asset Rank STLY Amount $m No of issues Share % STLY Share %
  • Last updated
  • 15 Jan 2019
Bookrunners of Asia Pacific (ex-Japan) G3 DCM 23 48 83.15 1 0.89% 0.09%
Bookrunners of Asia-Pac (ex-Japan) ECM 20 1 11.98 1 0.62% 9.80%

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 28,736.25 82 9.49%
2 JPMorgan 26,609.28 77 8.79%
3 Barclays 19,197.35 50 6.34%
4 HSBC 18,884.90 60 6.24%
5 BNP Paribas 18,849.94 38 6.23%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Bank of America Merrill Lynch 9,498.80 2 86.78%
2 Swedbank 160.81 1 1.47%
2 Sumitomo Mitsui Financial Group 160.81 1 1.47%
2 SEB 160.81 1 1.47%
2 Nordea 160.81 1 1.47%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 ING 220.22 2 15.39%
1 Bank of America Merrill Lynch 220.22 2 15.39%
1 ABN AMRO Bank 220.22 2 15.39%
4 Morgan Stanley 114.77 1 8.02%
4 BNP Paribas 114.77 1 8.02%